Clinical trial
Does Clear Priming of the Cardiopulmonary Bypass Circuit Reduce Bypass Associated Inflammation in Ventricular Septal Defect Patients?
NCT07393243 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Clear Priming of the Cardiopulmonary Bypass Circuit Reduce Bypass Associated Inflammation in Ventricular Septal Defect Patients?
- Lead sponsor
- Seattle Children's Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 25, 2026
- Completion date
- December 31, 2030
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ventricular septal defect